Correlation between initial cerebrospinal fluid orexin levels and longitudinal changes in clinical characteristics in Parkinson’s disease.

The table shows Spearman’s rank correlation coefficients for initial orexin levels and longitudinal changes in clinical characteristics. There was no significant correlation between initial CSF orexin levels and longitudinal changes in clinical characteristics. 95%CI, 95% confidence interval; Δ-, increment of -; ESS, Epworth Sleepiness Scale; RBDQ, Rapid Eye Movement Sleep Behavior Disorder Questionnaire; HYscale, Hoehn and Yahr scale; MDS-UPDRS(I)—(IV), Movement Disorder Society—unified Parkinson’s Disease Rating Scale part 1 to 4; PDQ-39, Parkinson’s Disease Questionnaire; MMSE, Mini-Mental State Examination; FAB, Frontal Assessment Battery; Olfactory, Olfactory identification score; SCOPA-AUT, Scales for Outcomes in Parkinson’s Disease-Autonomic; GDS-15, Geriatric Depression Scale; AS, Apathy Scale.
(XLSX)